Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti parasitic Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103554019A details a safer Tilbroquinol route avoiding toxic methyl iodide. Discover cost reduction in API manufacturing and high-purity supply solutions.
Patent CN102925528B reveals a novel nitrilase-catalyzed route for high-purity levo-praziquantel intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113683496A details a novel synthetic route for Agrimonol B and Pseudoaspidinol, offering cost reduction in API manufacturing through safer reagents and higher yields.
Novel CDI-catalyzed method ensures high purity nitazoxanide. Reduces impurities significantly for reliable pharmaceutical intermediate supply chain.
Discover how new buparvaquone synthesis achieves 60%+ yield and 99.5% purity without silver catalysts. Reduce costs and supply chain risks for bovine Taylor disease treatment.
Solve triclabendazole synthesis challenges with 55-60% yield, reduced H2S emissions, and EP-compliant quality. Find reliable suppliers for bulk production.